Barclays PLC Has $180,000 Stock Holdings in Semler Scientific, Inc. (NASDAQ:SMLR)

Barclays PLC lowered its holdings in Semler Scientific, Inc. (NASDAQ:SMLR) by 32.1% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 7,664 shares of the company’s stock after selling 3,626 shares during the quarter. Barclays PLC owned 0.11% of Semler Scientific worth $180,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in SMLR. Cerity Partners LLC boosted its position in shares of Semler Scientific by 91.5% in the third quarter. Cerity Partners LLC now owns 1,345,586 shares of the company’s stock valued at $31,689,000 after acquiring an additional 642,982 shares during the period. Shariaportfolio Inc. bought a new stake in Semler Scientific in the 3rd quarter valued at $3,618,000. AQR Capital Management LLC grew its position in Semler Scientific by 150.1% in the 2nd quarter. AQR Capital Management LLC now owns 140,498 shares of the company’s stock worth $4,833,000 after purchasing an additional 84,314 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Semler Scientific by 18.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 126,177 shares of the company’s stock worth $4,341,000 after purchasing an additional 19,552 shares during the period. Finally, State Street Corp raised its position in shares of Semler Scientific by 0.6% during the third quarter. State Street Corp now owns 118,223 shares of the company’s stock valued at $2,784,000 after buying an additional 725 shares during the last quarter. 49.37% of the stock is owned by institutional investors.

Semler Scientific Trading Down 6.3 %

SMLR opened at $55.24 on Wednesday. The stock’s 50 day simple moving average is $55.94 and its 200-day simple moving average is $38.21. The stock has a market cap of $511.91 million, a PE ratio of 26.95 and a beta of 1.18. Semler Scientific, Inc. has a 1 year low of $20.88 and a 1 year high of $81.56.

Semler Scientific (NASDAQ:SMLR) last released its quarterly earnings data on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.35. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%. The firm had revenue of $13.51 million during the quarter.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.